PureBMC®
GenesisCS Component Concentrating System
Providing the next generation
of regenerative therapies.
Call us today at
(877) 887-3436
We are a distributor of amnion-derived products and other medical solutions to physicians, surgeons, clinics, and hospitals.
PureBMC®
PureBMC® is Better Than Ever
PureBMC® is better than ever and remains the flawless solution to Bone Marrow Cell Concentrate. PureBMC® processes BMC in a system that remains closed and sterile throughout all steps of processing. This is especially important when processing in a surgical suite. It is also proven to concentrate viable platelets, hematopoietic stem cells (HSC), total nucleated cells (TNC) and mesenchymal stem cells (MSC) in a bath of plasma with a low hematocrit. PureBMC® can be prepared with or without Heparin, either way it provides viable platelet concentrates that further add to the strength of the cell composition. PureBMC® delivers the excellence and reliability physicians can depend on.
Higher HSC Concentrations
Hematopoietic stem cells (HSCs) are the blood cells that has the ability to replenish all blood cell types (Multipotency) and the ability to self-renew. This include monocytes, macrophages, erythrocytes, megakaryocytes, platelets, neutrophils, basophils, eosinophils, dendritic cells and lymphoid lineage cells.
Higher MSC Concentrations
Mesenchymal stem cells (MSC) are multipotent stromal cells that can differentiate into a variety of cell types. These cell types primarily include cartilage, bone and adipose cells. Mesenchymal stem cells are found in very small quantities in bone marrow aspirate, making the concentrating capabilities of PureBMC® more vital to the physician.
Higher TNC Concentrations
Total nucleated cell count by any method is a count of cells with nuclei. In order to properly represent the TNC cell count a correction calculation that removes nucleated red blood cells (nRBCs) is performed. It is understood, as in other therapies, that more cells = better outcomes.
PureBMC® has been designed to improve performance outcomes. The design details allows the end user to more accurately collect high therapeutic cell concentrates with low red blood cell content.
Same Great Outcomes
Hematopoietic stem cells (CD34+), total nucleated cell (TNC), mesenchymal stem cell (CFU-F) and platelet isolation is perfected in the PureBMC® system. PureBMC® retains high concentrations of these cell types with the lowest concentrations of red blood cells in a bone marrow concentrate product. Using a specialized cell isolation technique, PureBMC® provide more than 9X cell concentration in 7mL of PureBMC® . Preparation times are less than 10 minutes at the point of care. With careful attention to the details of gradient cell isolation, PureBMC® is a viable choice for a low hematocrit and high yielding bone marrow cell concentrate product.
Features and Benefits
Selectable Volumes & Concentrations
PureBMC® provide selectable sample volumes ranging from 3mL to 14mL. No matter what the sample size, PureBMC® provide therapeutic cell counts that exceed industry standards.
Ongoing Performance Analysis Report Campaign
See the Ongoing Performance Analysis Report Campaign, for PureBMC® at http://www.emcyte.com for the “always current” and up-to-date analysis of the performance of the PureBMC® system. This system was developed to provide objectivity and transparency in the clinical performance of the EmCyte systems. To be a participant in sample submission, call 239-481-7725 or visit the website for more information.
Call us today at
(877) 887-3436
REGENISOURCE PROVIDES THE NEXT GENERATION OF REGENERATIVE THERAPIES.
TESTIMONIALS
“My knee injections with amnio did exceptionally well for me, even letting me return in to competitive cycling. I put 1000 miles on my racing bike last year, only 6 months after my amnio injections.”
“In my 7 years using human placental tissue allografts patients experienced a more rapid recovery time than conventional standard of care treatments. Patients and I noted a significant decrease in inflammation/ swelling which reduces pain and increases function. Unlike cortisone which has a long list of side effects, no adverse events have ever been reported using these placental tissue allograft.”